Ivana K.
- Country
- Czechia
- Department
- Dermatovenerology
Research Overview
- A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastatic or Unresectable Melanoma
- Evaluation of Neoadjuvant and Adjuvant mRNA-4157 with Pembrolizumab Versus Standard of Care in Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma
- Phase 3 Randomized Double-Blind Trial of Nivolumab and Relatlimab Versus Nivolumab Monotherapy in Stage III-IV Melanoma Post-Resection
Data & Insights
Has run more than one trial at 98 of 242 partner sites.
Specializations
Melanoma Research
Primary focus on advanced therapeutic approaches for cutaneous melanoma, including investigations in both early and late-stage disease management. Expertise extends to adjuvant immunotherapy and targeted treatments for various melanoma stages.
- Stage IIB/C melanoma treatment
- Metastatic melanoma interventions
- NRAS mutant melanoma therapy
Specializes in both resectable and unresectable disease conditions, with particular attention to novel therapeutic combinations.
Immunotherapy Innovation
Conducts research in advanced immunotherapy approaches, particularly focusing on combination therapies and novel drug administration methods. Investigates both subcutaneous and intravenous treatment delivery systems.
- Nivolumab-based treatments
- Relatlimab combinations
- Fixed-dose combination therapies
Explores innovative therapeutic strategies in both adjuvant and metastatic disease settings.
Skin Cancer Therapeutics
Investigates treatment approaches for cutaneous squamous cell carcinoma and other skin malignancies. Works with targeted therapies and solid tumor interventions.
- Resectable skin cancer treatment
- Novel therapeutic combinations
- Targeted molecular therapies
Focuses on developing treatment strategies for locally advanced and metastatic skin cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.